Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing re-evaluation of Zhuifengtougu Capsules for cervical spondylosis
ChiCTR2000028807Phase 4Recruiting
- Sponsor
- Temporarily not sure
- Start
- Sep 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of zhuifengtougu in cervical osteoarthritis (2 arms), sponsored by Temporarily not sure. Primary endpoint: Score of symptoms and signs related to cervical spondylosis. Started Sep 2019; status: recruiting.
02
Drugs
zhuifengtougu
03
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on ChiCTR2000028807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028807.